{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:40:11Z","timestamp":1789202411160,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National High Level Hospital","award":["NHLHCRF-YS-02"],"award-info":[{"award-number":["NHLHCRF-YS-02"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171788"],"award-info":[{"award-number":["82171788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371810"],"award-info":[{"award-number":["82371810"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372320"],"award-info":[{"award-number":["82372320"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["ZRJY2021-GG13"],"award-info":[{"award-number":["ZRJY2021-GG13"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1136\/ard-2023-225284","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T13:31:51Z","timestamp":1708695111000},"page":"775-786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification"],"prefix":"10.1016","volume":"83","author":[{"given":"Shiyu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2023-225284_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1136\/ard-2023-225284_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2023-225284_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.autrev.2009.03.005","article-title":"Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies","volume":"9","author":"R\u00f6nnelid","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2023-225284_bib4","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1093\/rheumatology\/keq281","article-title":"Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay","volume":"49","author":"Ghirardello","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225284_bib5","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.162.4.2315","article-title":"Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease","volume":"162","author":"Hirakata","year":"1999","journal-title":"J Immunol"},{"key":"10.1136\/ard-2023-225284_bib6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","article-title":"Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia","volume":"46","author":"Betteridge","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225284_bib7","first-page":"S312","article-title":"Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome (abstract)","volume":"52","author":"Hashish","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2023-225284_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103204","article-title":"Two novel anti-aminoacyl tRNA synthetase antibodies: autoantibodies against cysteinyl-tRNA synthetase and valyl-tRNA synthetase","volume":"21","author":"Muro","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2023-225284_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102951","article-title":"Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies","volume":"134","author":"Preger","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1136\/ard-2023-225284_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semarthrit.2016.03.011","article-title":"Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group","volume":"46","author":"Trallero-Aragu\u00e1s","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard-2023-225284_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejim.2013.01.002","article-title":"Clinical manifestations and outcome of anti-Pl7 positive patients with antisynthetase syndrome","volume":"24","author":"Marie","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1136\/ard-2023-225284_bib12","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s10067-020-04979-8","article-title":"Clinical features and outcomes of the patients with anti-Glycyl tRNA synthetase syndrome","volume":"39","author":"Zhang","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2023-225284_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10067-022-06404-8","article-title":"Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China","volume":"42","author":"Wang","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2023-225284_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","article-title":"Comparison of long-term outcome between anti-Jo1- and anti-Pl7\/Pl12 positive patients with antisynthetase syndrome","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2023-225284_bib15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-Pl7 and anti-Pl12 autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225284_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","article-title":"Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity","volume":"12","author":"Hervier","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2023-225284_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8112013","article-title":"Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course","volume":"8","author":"Cavagna","year":"2019","journal-title":"J Clin Med"},{"key":"10.1136\/ard-2023-225284_bib18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3899\/jrheum.161480","article-title":"Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies","volume":"44","author":"Shi","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2023-225284_bib19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"10.1136\/ard-2023-225284_bib20","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-Melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2023-225284_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845988","article-title":"Different multivariable risk factors for rapid progressive interstitial lung disease in anti-MDA5 positive dermatomyositis and anti-synthetase syndrome","volume":"13","author":"Zuo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2023-225284_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.42308","article-title":"Identification of three different phenotypes in anti\u2013melanoma differentiation\u2013associated gene 5 antibody\u2013positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease","volume":"75","author":"Xu","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2023-225284_bib23","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"10.1136\/ard-2023-225284_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cvsm.2016.10.004","article-title":"A quick reference on hypoxemia","volume":"47","author":"Bach","year":"2017","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1136\/ard-2023-225284_bib25","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1136\/ard-2023-225284_bib26","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1161\/hc4801.100076","article-title":"Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects","volume":"104","author":"McQuillan","year":"2001","journal-title":"Circulation"},{"key":"10.1136\/ard-2023-225284_bib27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225284_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117321","article-title":"Decrease in cell counts and alteration of phenotype characterize peripheral NK cells of patients with anti-MDA5-positive dermatomyositis","volume":"543","author":"Lin","year":"2023","journal-title":"Clinica Chimica Acta"},{"key":"10.1136\/ard-2023-225284_bib29","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s10067-019-04503-7","article-title":"The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies","volume":"38","author":"Li","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2023-225284_bib30","article-title":"Clinical features, prognostic factors, and survival of patients with antisynthetase syndrome and interstitial lung disease","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2023-225284_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2023-225284_bib32","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10067-015-3023-x","article-title":"Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)","volume":"34","author":"Rojas-Serrano","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard-2023-225284_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120313","article-title":"Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study","volume":"10","author":"Hozumi","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1136\/ard-2023-225284_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir Med"},{"key":"10.1136\/ard-2023-225284_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rmed.2017.04.007","article-title":"The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies","volume":"127","author":"Tanizawa","year":"2017","journal-title":"Respir Med"},{"key":"10.1136\/ard-2023-225284_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","article-title":"Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study","volume":"8","author":"Vuillard","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1136\/ard-2023-225284_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/qjmed\/hcac045","article-title":"Isolated interstitial lung disease associated with anti-synthetase syndrome","volume":"115","author":"Acharya","year":"2022","journal-title":"QJM"},{"key":"10.1136\/ard-2023-225284_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fmed.2020.00363","article-title":"Predictors and mortality of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathy: a series of 474 patients","volume":"7","author":"Li","year":"2020","journal-title":"Front Med"},{"key":"10.1136\/ard-2023-225284_bib39","doi-asserted-by":"crossref","first-page":"L915","DOI":"10.1152\/ajplung.00266.2015","article-title":"Platelets in the pathogenesis of acute respiratory distress syndrome","volume":"309","author":"Yadav","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1136\/ard-2023-225284_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/biomedicines8070230","article-title":"Antiplatelet therapy for acute respiratory distress syndrome","volume":"8","author":"Chen","year":"2020","journal-title":"Biomedicines"},{"key":"10.1136\/ard-2023-225284_bib41","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1073\/pnas.052715199","article-title":"A prototypic platelet Septin and its participation in secretion","volume":"99","author":"Dent","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2023-225284_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/imr.12559","article-title":"Crucial role for CD69 in allergic inflammatory responses: CD69-Myl9 system in the pathogenesis of airway inflammation","volume":"278","author":"Kimura","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1136\/ard-2023-225284_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00281-019-00734-7","article-title":"A new therapeutic target: the CD69-Myl9 system in immune responses","volume":"41","author":"Kimura","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1136\/ard-2023-225284_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood-2008-03-145821","article-title":"Fibrinogen is required for maintenance of platelet intracellular and cell-surface P-selectin expression","volume":"114","author":"Yang","year":"2009","journal-title":"Blood"},{"key":"10.1136\/ard-2023-225284_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","article-title":"Risk factors and disease mechanisms in myositis","volume":"14","author":"Miller","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2023-225284_bib46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1136\/ard-2023-225284_bib47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40265-014-0240-6","article-title":"Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment","volume":"74","author":"Hornung","year":"2014","journal-title":"Drugs"},{"key":"10.1136\/ard-2023-225284_bib48","article-title":"Five genes as diagnostic biomarkers of dermatomyositis and their correlation with immune cell infiltration","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2023-225284_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008002","article-title":"Inducible LGALS3BP\/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex","volume":"15","author":"Xu","year":"2019","journal-title":"PLoS Pathog"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672400133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672400133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2023-225284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:16:01Z","timestamp":1737418561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672400133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S000349672400133X"],"URL":"https:\/\/doi.org\/10.1136\/ard-2023-225284","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2023-225284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by Elsevier Inc. on behalf of EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}